Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Ginseng is possibly safe but its effectiveness is unclear due to poor quality studies and mixed results.

Finasteride improves hair loss in women with hyperandrogenism.

Minoxidil and finasteride effectively treat hair loss.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Platelet-rich plasma might help tissue regeneration in dentistry, but results vary and more research is needed.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.